In gastric cancer, laparoscopic gastrectomy is commonly performed in Asian countries. In other regions where tumor incidence is relatively low and patient characteristics are different, developments in this issue have been limited. In this study, the investigators aimed to compare the early results for patients who underwent open or laparoscopic gastrectomy for gastric cancer in a center in Turkey.
The patients who were operated in Kocaeli Derince Training and Research Hospital between January 2014 and January 2019 consecutively due to gastric cancer were analyzed. The diagnosis was made by upper gastrointestinal endoscopy and endoscopic biopsy. Clinical staging was done using contrast computed tomography (CT). Positron emission tomography (PET) was used in patients with suspected metastasis.The patients were divided into two groups according to the technique applied (open, laparotomy). The first group (Group 1; n: 30) consisted of patients who underwent open surgery, and the second group (Group 2, n: 30) laparoscopic surgery.
Study Type
OBSERVATIONAL
Enrollment
60
gastric resection with lymph node dissection(D1+,D2) for stomach cancer.
Kocaeli Derince Training and research Hospital
Kocasinan, Derince, Turkey (Türkiye)
Age
year
Time frame: 2014-2019
Body mass index
kg/m2
Time frame: 2014- 2019
Previous abdominal surgery status
yes or no
Time frame: 2014-2019
Comorbidity status
present or absent
Time frame: 2014 -2019
Neoadjuvant therapy status
present or absent
Time frame: 2014-2019
American Society of Anesthesiologists (ASA) score
1,2,3,4
Time frame: 2014-2019
Gender
male or female
Time frame: 2014-2019
Surgical technique
open or laparoscopic
Time frame: 2014-2019
Tumor localization
proximal, middle, lower
Time frame: 2014 - 2019
Gastrectomy type
total, subtotal
Time frame: 2014 - 2019
Lymph node dissection type
D1+, D2
Time frame: 2014 - 2019
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Operation time
minute
Time frame: 2014 - 2019
Blood loss
ml
Time frame: 2014 - 2019
Complication (Clavien-Dindo Classification)
1,2,3 A,3 B,4 A,4 B,5 (according to Clavien-Dindo Classification)
Time frame: 2014 - 2019
30-day mortality
present or absent
Time frame: 2014 - 2019
Number of harvested lymph node
number
Time frame: 2014 - 2019
Resection margin status
positive or negative
Time frame: 2014 - 2019
Tumor stage (American Joint Committee on Cancer 8th Edition)
0,1,2 A,2 B,3,4 A, 4 B (According to American Joint Committee on Cancer 8th Edition)
Time frame: 2014 - 2019